LoginRegister
    Novartis cancer therapy MET inhibitor capmatinib granted USFDA priority reviewNovartis cancer therapy MET inhibitor capmatinib granted USFDA priority review
    Wockhardt sells Baddi plant, 62 drug brands to Dr Reddys for Rs 1850 croreWockhardt sells Baddi plant, 62 drug brands to Dr Reddys for Rs 1850 crore
    Granules India gets tentative USFDA nod for generic Colchicine capsulesGranules India gets tentative USFDA nod for generic Colchicine capsules
    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDASun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA
    J B Chemicals Gujarat unit gets EIR from USFDAJ B Chemicals Gujarat unit gets EIR from USFDA
    Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditionsZydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions
    All medical devices to be classified as DRUGS, detailsAll medical devices to be classified as DRUGS, details
    Sanofi asks US court to halt diabetes drug patent fight with MylanSanofi asks US court to halt diabetes drug patent fight with Mylan
    First of its kind: ResMed organises sleep summit in IndiaFirst of its kind: ResMed organises sleep summit in India
    NPPA fixes price of 21 formulations including diabetes drugs, others; DetailsNPPA fixes price of 21 formulations including diabetes drugs, others; Details
    Cipla arm inks pact for anti-psychotic drug QuetiapineCipla arm inks pact for anti-psychotic drug Quetiapine
    Cadila Healthcare Ahmedabad facility gets EIR from USFDACadila Healthcare Ahmedabad facility gets EIR from USFDA
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X